Visualization of the gall bladder on F-18 FDOPA PET imaging: A potential pitfall

Clinical Nuclear Medicine

Volumn 30, Issue 1, 2005, Pages 23-24

  Balan, Kottekkattu K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Diagnostic pitfall; F 18 FDOPA PET; Tumor imaging

Indexed keywords

DOPA; DOPAMINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; DIAGNOSTIC IMAGING; DOPAMINE METABOLISM; DRUG EXCRETION; EARLY DIAGNOSIS; GALLBLADDER; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; LIVER METASTASIS; MOTOR DYSFUNCTION; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY;

ARTIFACTS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DIHYDROXYPHENYLALANINE; GALLBLADDER; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 11144334876     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200501000-00006     Document Type: Article

References (8)

1. Jacob T, Grahek D, Younsi N, et al. Positron emission tomography with [(18)F] FDOPA and [(18)] FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging. 2003;30:1266-1269.
2. Hoegerle S, Altehoefer C, Koehler G, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumours. Radiology. 2001;220:373-380.
3. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137-142.
4. Dimitrakopoulou-Strauss A, Strauss LG, Burger C. Quantitative PET studies in pre-treated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and non-compartment analysis. J Nucl Med. 2001;42:248-256.
5. Nagasawa H, Tanji H, Itoyama Y, et al. Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography. J Neurol Sci. 1996;144:70-76.
6. Heiss WD, Hiker R. The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease. Eur J Neurol. 2004;11:5-12.
7. Dhavan V, Ma Y, Pillai V, et al. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med. 2002;43:1324-1330.
8. Ishikawa T, Dhavan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine 123-beta CIT-FP/SPECT and fluorine-18-FDOPA/ PET. J Nucl Med. 1996;37:1760-1765.